Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.
2.

Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.

Brugts JJ, Ferrari R, Simoons ML.

Expert Rev Cardiovasc Ther. 2009 Apr;7(4):345-60. doi: 10.1586/erc.09.2. Review. Erratum in: Expert Rev Cardiovasc Ther. 2009 Jun;7(6):722.

PMID:
19379059
3.
4.

[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].

Rapezzi C, Ciliberti P, Graziosi M, Riva L.

Ital Heart J. 2005 Nov;6 Suppl 7:40S-47S. Review. Italian.

PMID:
16485516
5.
6.

Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.

Ionescu DD; PREFER Investigators..

Clin Drug Investig. 2009;29(12):767-76. doi: 10.2165/11319700-000000000-00000.

PMID:
19888783
7.
8.

Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.

Ferrari R.

Expert Rev Cardiovasc Ther. 2005 Jan;3(1):15-29. Review.

PMID:
15723572
9.

Dosage considerations with perindopril for systemic hypertension.

Sica DA.

Am J Cardiol. 2001 Oct 4;88(7A):13i-18i. Review.

PMID:
11591356
10.

Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine.

Ferrari R.

Curr Med Res Opin. 2008 Dec;24(12):3543-57. doi: 10.1185/03007990802576302 . Review.

PMID:
19032136
11.
12.

Evidence for benefits of perindopril in hypertension and its complications.

Laurent S.

Am J Hypertens. 2005 Sep;18(9 Pt 2):155S-162S. Review.

PMID:
16125052
13.

Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.

Mourad JJ, Le Jeune S, Pirollo A, Mourad C, Gaudouen Y, Lopez-Sublet M.

Curr Med Res Opin. 2010 Sep;26(9):2263-76. doi: 10.1185/03007995.2010.510925. Review.

PMID:
20690889
14.

Development and in vitro/in vivo evaluation of immediate release perindopril tablets.

Ölçer M, Ölçer A, İnce İ, Karasulu E.

Pharm Dev Technol. 2015;20(6):684-93. doi: 10.3109/10837450.2014.915568. Epub 2014 May 6.

PMID:
24799074
15.

Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension.

Hatala R, Pella D, Hatalová K, Šidlo R.

Clin Drug Investig. 2012 Sep 1;32(9):603-12. doi: 10.2165/11634530-000000000-00000.

PMID:
22877321
16.

Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.

Matheson AJ, Cheer SM, Goa KL.

Drugs. 2001;61(8):1211-29. Review.

PMID:
11465878
17.

A review of Perindopril in the reduction of cardiovascular events.

Campbell DJ.

Vasc Health Risk Manag. 2006;2(2):117-24. Review.

18.

Specific properties and effect of perindopril in controlling the renin-angiotensin system.

Ferrari R, Pasanisi G, Notarstefano P, Campo G, Gardini E, Ceconi C.

Am J Hypertens. 2005 Sep;18(9 Pt 2):142S-154S. Review.

PMID:
16125051
19.

Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.

Morimoto S, Maki K, Aota Y, Sakuma T, Iwasaka T.

Hypertens Res. 2008 Aug;31(8):1603-10. doi: 10.1291/hypres.31.1603.

PMID:
18971536
20.

Perindopril.

Alfakih K, Hall AS.

Expert Opin Pharmacother. 2006 Jan;7(1):63-71. Review.

PMID:
16370923

Supplemental Content

Support Center